Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis

BACKGROUND: Several major randomized control studies have demonstrated that mepolizumab, an anti-IL-5 monoclonal antibody, is effective for patients with severe eosinophilic asthma who show exacerbation or require systemic corticosteroid maintenance therapy. However, the predictive factors of the re...

Full description

Saved in:
Bibliographic Details
Published in:BMC Pulm Med
Main Authors: Numata, Takanori, Nakayama, Katsutoshi, Utsumi, Hirofumi, Kobayashi, Kenji, Yanagisawa, Haruhiko, Hashimoto, Mitsuo, Minagawa, Shunsuke, Ishikawa, Takeo, Hara, Hiromichi, Araya, Jun, Kuwano, Kazuyoshi
Format: Artigo
Language:Inglês
Published: BioMed Central 2019
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790020/
https://ncbi.nlm.nih.gov/pubmed/31606052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0952-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items